Targeted inhibition of gut microbiota proteins involved in TMAO production to reduce platelet aggregation and arterial thrombosis: a blueprint for drugging the microbiota in the treatment of cardiometabolic disease?
| Autor: | Max Nieuwdorp, T E van Mens, H. R. Büller |
|---|---|
| Přispěvatelé: | Graduate School, Vascular Medicine, ACS - Pulmonary hypertension & thrombosis, ACS - Diabetes & metabolism, AGEM - Digestive immunity, AGEM - Endocrinology, metabolism and nutrition |
| Rok vydání: | 2019 |
| Předmět: |
0301 basic medicine
Platelet aggregation biology business.industry Gastrointestinal Microbiome Hematology 030204 cardiovascular system & hematology Gut flora medicine.disease Cardiometabolic disease biology.organism_classification Thrombosis 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Immunology medicine business |
| Zdroj: | Journal of thrombosis and haemostasis, 17(1), 3-5. Wiley-Blackwell |
| ISSN: | 1538-7836 1538-7933 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text